Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia

Autor: Maria L. Salustiano-Bandeira, Amanda Moreira-Aguiar, Diego A. Pereira-Martins, Juan L. Coelho-Silva, Isabel Weinhäuser, Pedro L. França-Neto, Aleide S. Lima, Ana S. Lima, Anemari R. Baccarin, Fernanda B. Silva, Manuela A. de Melo, Fernanda S. Niemann, Luciana Nardinelli, César A. Ortiz Rojas, Bruno K. Duarte, Aderson S. Araujo, Elisa A. Azevedo, Clarice N. Morais, Lorena L. Figueiredo-Pontes, Jan J. Schuringa, Gerwin Huls, Israel Bendit, Eduardo M. Rego, Sara T. Olalla Saad, Fabiola Traina, Marcos A. Bezerra, Antonio R. Lucena-Araujo

Publikováno v: Blood Cancer Journal, Vol 14, Iss 1, Pp 1-3 (2024)

Externí odkaz: https://doaj.org/article/67ef150b7ee54451934361d769848375

Dysregulated Activating and Inhibitory Receptors on Natural Killer Cells Predicts Immune Escape and Poor Outcomes in Acute Myeloid Leukemia

Autor: Amanda F O Costa, Valeriya Kuznetsova, Leticia O Marani, Izabela A Lopes, Larissa S Binelli, Priscila S Scheucher, Josiane L Schiavinato, Joana T B Faria, Maria Isabel A Madeira, Katia B Pagnano, Bruno K Duarte, Ana Beatriz F Gloria, Eduardo M Rego, Fabiola Traina, Robert Welner, Lorena L Figueiredo-Pontes

Publikováno v: Blood. 140:9113-9114

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2b0852d333b91b483a2fd90c8f471445
https://doi.org/10.1182/blood-2022-168178

Results of FLT3 mutation screening and correlations with immunophenotyping in 169 Brazilian patients with acute myeloid leukemia

Autor: Antonio R. Lucena-Araujo, Danielle L. Souza, Fabio Morato de Oliveira, Mariana Tereza Lira Benicio, Lorena L. Figueiredo-Pontes, Barbara A. Santana-Lemos, Guilherme A. dos Santos, Rafael H. Jacomo, Anemari R. Dinarte-Santos, Mihoko Yamamoto, Wilson A. Silva-Jr, Maria de Lourdes Chauffaille, Eduardo M. Rego

Publikováno v: Annals of Hematology. 89:225-228

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8508958717fea204310b0c07643e195
https://doi.org/10.1007/s00277-009-0817-4

Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia.

Autor: Pereira-Martins DA; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil., Coelho-Silva JL; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil., Weinhäuser I; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil., Franca-Neto PL; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Silveira DR; Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Ortiz C; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil., Moreira-Aguiar A; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Lima MM; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Koury LC; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil., de Melo RA; Department of Internal Medicine, University of Pernambuco, Recife, Brazil., Glória AB; Hematology Division, Federal University of Minas Gerais, Belo Horizonte, Brazil., Fagundes EM; Hematology Division, Federal University of Minas Gerais, Belo Horizonte, Brazil., Lino BK; Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil., Pagnano K; Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil., Bittencourt R; Hematology Division, Federal University of Paraná, Curitiba, Brazil., Nunes E; Hematology Division, Federal University of Rio Grande do Sul, Porto Alegre, Brazil., Traina F; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil., Figueiredo-Pontes L; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil., Keating A; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Tallman MS; Leukemia Service, Memorial Sloan-Kettering Cancer Center/Weill Cornell Medical College, New York City, New York, USA., Ribeiro RC; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Dilon R; Department of Medical and Molecular Genetics, King's College London School of Medicine, London, UK., Ganser A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Sanz MA; Department of Hematology, Valencia University Medical School, Valencia, Spain.; CIBERONC, Instituto Carlos III, Madrid, Spain., Berliner N; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Valk P; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., Löwenberg B; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., Ottone T; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.; Santa Lucia Foundation, I.R.C.C.S., Neuro-Oncohematology, Rome, Italy., Noguera NI; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.; Santa Lucia Foundation, I.R.C.C.S., Neuro-Oncohematology, Rome, Italy., Voso MT; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.; Santa Lucia Foundation, I.R.C.C.S., Neuro-Oncohematology, Rome, Italy., Paoloni F; Santa Lucia Foundation, I.R.C.C.S., Neuro-Oncohematology, Rome, Italy., Fazi P; Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA), GIMEMA Foundation, Rome, Italy., Ammatuna E; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Huls G; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Schuringa JJ; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Rego EM; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil.; Hematology Division, LIM31, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil., Lucena-Araujo AR; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.

Publikováno v: British journal of haematology [Br J Haematol] 2023 Jan; Vol. 200 (2), pp. 170-174. Date of Electronic Publication: 2022 Oct 20.